Zhejiang Medical University, Harvard Medical School and United Biotechnology Co. build joint „Molecular Biotherapy Research Center“ inside Zhejiang University of Traditional Chinese Medicine

Apr 14, 2016

The 400 m2 laboratory will be led by Professor Guoping SHI of Harvard Medical School and focus on applications of regulatory T cell technology, e. g., for the treatment of lupus, organ transplantation and cancer.

China Bio news release, April 14, 2016

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny